Semaglutide causes weight loss through several simultaneous mechanisms: it mimics a natural gut hormone to suppress appetite in the brain, slows how quickly food leaves your stomach, and reduces the reward you get from eating. In two-year clinical trials, people taking the injectable form lost an average of 15.2% of their body weight, compared to 2.6% with a placebo.
It Mimics a Hormone Your Gut Already Makes
Your body naturally produces a hormone called GLP-1 (glucagon-like peptide-1) after you eat. GLP-1 signals your brain that food has arrived, helps regulate insulin, and promotes a feeling of fullness. The problem is that natural GLP-1 breaks down within minutes. Semaglutide is a synthetic version engineered to last much longer in the body, which is why it only needs to be taken once a week (injection) or once a day (oral tablet). By keeping GLP-1 receptors activated for an extended period, semaglutide amplifies and sustains the appetite-suppressing signals your body would normally produce only briefly after a meal.
What Happens in Your Brain
Semaglutide works on multiple brain regions at once. One key target is an area in the brainstem that lacks the usual blood-brain barrier, meaning it can directly detect signals from circulating hormones. When semaglutide activates receptors there, it enhances feelings of fullness and reduces the urge to eat by boosting signaling that promotes satiety. Those signals then get relayed up to the hypothalamus, which acts as the brain’s appetite control center.
In the hypothalamus, semaglutide tips the balance between two competing systems. It increases the activity of neurons that suppress appetite while dialing down neurons that stimulate hunger. It also influences nearby brain regions that regulate energy balance by reducing the activity of neurons responsible for stimulating appetite.
Perhaps the most noticeable effect for many people is what happens in the brain’s reward pathway. Semaglutide influences dopamine release in the areas linked to motivation, pleasure, and reward. This is the mechanism behind what patients describe as reduced “food noise,” the constant mental chatter about food, cravings for specific foods, and the pull toward highly palatable items like sweets or fried foods. The medication doesn’t eliminate the ability to enjoy eating, but it turns down the volume on compulsive food-seeking behavior.
It Slows Digestion
Semaglutide also acts on the digestive system by delaying gastric emptying, meaning food stays in your stomach longer than it normally would. This contributes to feeling full sooner during a meal and staying full longer afterward, which naturally leads to eating fewer calories without conscious effort. Research shows that semaglutide use is associated with a measurable increase in retained solid stomach contents. This slower digestion is part of why nausea is the most commonly reported side effect, particularly in the early weeks of treatment.
Metabolic Effects Beyond Appetite
Weight loss isn’t purely about eating less. Semaglutide also improves how your body handles blood sugar by preserving the function of insulin-producing cells, suppressing excess glucagon (a hormone that raises blood sugar), and reducing inflammation. These metabolic shifts mean your body processes energy more efficiently, which matters whether or not you have diabetes.
In the SELECT trial, which studied people with cardiovascular disease and elevated BMI who did not have diabetes, semaglutide reduced major adverse cardiovascular events (heart attack, stroke, or cardiovascular death) by 20%. This suggests the drug’s benefits extend well beyond the number on a scale.
The Dosing Schedule
Semaglutide for weight loss is prescribed under the brand name Wegovy. The dose starts low and increases gradually over about four months. For the injectable version, you begin at 0.25 mg once a week for the first four weeks, then step up to 0.5 mg, then 1 mg, then 1.7 mg, before reaching the maintenance dose of 2.4 mg per week starting around week 17. An oral tablet version follows a similar ramp-up, starting at 1.5 mg daily and increasing over 90 days to a maintenance dose of 25 mg daily.
This gradual titration exists specifically to reduce side effects. Starting at the full dose would cause significantly worse nausea and gastrointestinal discomfort. Even with the slow ramp-up, about 28% of people experience nausea, 12% experience vomiting, 10% have diarrhea, and 6% deal with constipation. These side effects are generally worst in the early weeks and during dose increases, then tend to improve as the body adjusts.
How Much Weight People Actually Lose
In the STEP 5 clinical trial, which tracked participants over two full years, people taking semaglutide 2.4 mg lost an average of 15.2% of their starting body weight. For someone weighing 220 pounds, that works out to roughly 33 pounds. The placebo group lost only 2.6% over the same period. Importantly, weight loss was sustained over the two years, not just an initial drop that plateaued.
Individual results vary considerably. Some people lose more than 20% of their body weight, while others see more modest results. Factors like starting weight, diet, physical activity, and individual biology all play a role.
The Muscle Loss Concern
One important caveat is that semaglutide doesn’t only reduce fat. In the STEP 1 trial, about 45% of the total weight lost came from lean mass (which includes muscle), not fat. That ratio is notably higher than what’s typically seen with standard weight loss, where roughly one-quarter of weight lost comes from lean tissue.
This matters because losing muscle can reduce your metabolic rate, decrease strength, and affect mobility, particularly in older adults. Resistance training and adequate protein intake during treatment are widely recommended to help preserve muscle mass, though the drug’s appetite-suppressing effects can make eating enough protein a challenge in practice.